Export

Insulin detemir
Essential medicine status
General description

INN
Insulin detemir
Medicine type
Biological agent
EML status history
Application rejected in 2019 (TRS 1021) for Type 1 diabetes mellitus
Changed in 2021 (TRS 1035) for Type 1 diabetes mellitus
Changed in 2021 (TRS 1035) for Type 2 diabetes mellitus
Therapeutic equivalent for
insulin glargine for Type 1 diabetes mellitus
long-acting insulin analogues for Type 1 diabetes mellitus
long-acting insulin analogues for Type 2 diabetes mellitus
Wikipedia
Insulin detemir
DrugBank
Insulin detemir